141 related articles for article (PubMed ID: 25022599)
1. Myelomastocytic leukemia with aberrant CD25 expression: case report and review of the literature.
Rich A; Sun J; Aldayel AS; Yin CC; Medeiros LJ; Konoplev S
Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):e173-7. PubMed ID: 25022599
[No Abstract] [Full Text] [Related]
2. [Neoplastic mastocytosis evolving from a poor prognosis acute myeloid leukemia].
Chen-Liang TH; Jerez A; Florensa L; Ortuño FJ
Med Clin (Barc); 2015 Jun; 144(12):571-2. PubMed ID: 25249393
[No Abstract] [Full Text] [Related]
3. Aberrant phenotype of plasmacytoid monocytes in acute myeloid leukemia.
Boveri E; Castagnola C; Castello A; Magrini U
Am J Hematol; 2008 May; 83(5):428-9. PubMed ID: 17617786
[No Abstract] [Full Text] [Related]
4. Systemic mastocytosis associated with acute myeloid leukaemia.
Fong C; Tong M
Pathology; 2010; 42(5):485-7. PubMed ID: 20632831
[No Abstract] [Full Text] [Related]
5. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M
Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
[TBL] [Abstract][Full Text] [Related]
6. Therapy-related acute leukemia with mixed phenotype and t(9;22)(q32;q11.2): a case report and review of the literature.
Cho JH; Hur M; Moon HW; Yun YM; Ko YS; Kim WS; Lee MH
Hum Pathol; 2012 Apr; 43(4):605-9. PubMed ID: 22036054
[TBL] [Abstract][Full Text] [Related]
7. Mast cell differentiation of leukemic blasts in diverse myeloid neoplasms: A potential pre-myelomastocytic leukemia condition.
Panda D; Chatterjee G; Khanka T; Ghogale S; Badrinath Y; Deshpande N; Sardana R; Chaturvedi A; Rajpal S; Shetty D; Patkar NV; Gujral S; Subramanian PG; Tembhare PR
Cytometry B Clin Cytom; 2021 May; 100(3):331-344. PubMed ID: 32738100
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome.
Garcia-Manero G; Tambaro FP; Bekele NB; Yang H; Ravandi F; Jabbour E; Borthakur G; Kadia TM; Konopleva MY; Faderl S; Cortes JE; Brandt M; Hu Y; McCue D; Newsome WM; Pierce SR; de Lima M; Kantarjian HM
J Clin Oncol; 2012 Jun; 30(18):2204-10. PubMed ID: 22585696
[TBL] [Abstract][Full Text] [Related]
9. A case of leukemia of the appendix presenting as acute appendicitis.
Toubai T; Kondo Y; Ogawa T; Imai A; Kobayashi N; Ogasawara M; Kiyama Y; Higa T; Sato K; Miyokawa N; Tanaka J; Imamura M; Kasai M
Acta Haematol; 2003; 109(4):199-201. PubMed ID: 12853694
[TBL] [Abstract][Full Text] [Related]
10. T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia.
Mantadakis E; Danilatou V; Stiakaki E; Paterakis G; Papadhimitriou S; Kalmanti M
Pediatr Blood Cancer; 2007 Mar; 48(3):354-7. PubMed ID: 16206214
[TBL] [Abstract][Full Text] [Related]
11. Acute myeloid leukemia with T-cell receptor gamma gene rearrangement occurring in a patient with chronic lymphocytic leukemia: a case report.
Hatoum HA; Mahfouz RA; Otrock ZK; Hudaib AR; Taher AT; Shamseddine AI
Am J Hematol; 2007 Jan; 82(1):69-72. PubMed ID: 16947317
[TBL] [Abstract][Full Text] [Related]
12. De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child.
Zheng Y; Nong L; Liang L; Wang W; Li T
Diagn Pathol; 2018 Feb; 13(1):14. PubMed ID: 29458385
[TBL] [Abstract][Full Text] [Related]
13. Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemia.
Gojo I; Tan M; Fang HB; Sadowska M; Lapidus R; Baer MR; Carrier F; Beumer JH; Anyang BN; Srivastava RK; Espinoza-Delgado I; Ross DD
Clin Cancer Res; 2013 Apr; 19(7):1838-51. PubMed ID: 23403629
[TBL] [Abstract][Full Text] [Related]
14. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
Valent P; Sperr WR; Samorapoompichit P; Geissler K; Lechner K; Horny HP; Bennett JM
Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
[TBL] [Abstract][Full Text] [Related]
15. Acute Myeloid Leukemia Diagnosed 5 Years after Adult T-Cell Leukemia/Lymphoma.
Owatari S; Arai A; Tsuruta T; Haraguchi K; Otsuka M; Hanada S
J Clin Exp Hematop; 2015; 55(1):29-31. PubMed ID: 26106004
[TBL] [Abstract][Full Text] [Related]
16. A phase I study of vorinostat in combination with idarubicin in relapsed or refractory leukaemia.
Kadia TM; Yang H; Ferrajoli A; Maddipotti S; Schroeder C; Madden TL; Holleran JL; Egorin MJ; Ravandi F; Thomas DA; Newsome W; Sanchez-Gonzalez B; Zwiebel JA; Espinoza-Delgado I; Kantarjian HM; Garcia-Manero G
Br J Haematol; 2010 Jul; 150(1):72-82. PubMed ID: 20456355
[TBL] [Abstract][Full Text] [Related]
17. Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge.
Arredondo AR; Gotlib J; Shier L; Medeiros B; Wong K; Cherry A; Corless C; Arber DA; Valent P; George TI
Am J Hematol; 2010 Aug; 85(8):600-6. PubMed ID: 20658589
[No Abstract] [Full Text] [Related]
18. Acute myeloid leukemia mimicking primary testicular neoplasm. Presentation of a case with review of literature.
McIlwain L; Sokol L; Moscinski LC; Saba HI
Eur J Haematol; 2003 Apr; 70(4):242-5. PubMed ID: 12656749
[TBL] [Abstract][Full Text] [Related]
19. Very rare lineage switch from acute myeloid leukemia to mixed phenotype acute leukemia, B/Myeloid, during chemotherapy with no clonal evolution.
Nomani L; Cook JR; Rogers HJ
Int J Lab Hematol; 2019 Aug; 41(4):e86-e88. PubMed ID: 30707502
[No Abstract] [Full Text] [Related]
20. Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasms.
Ye XN; Zhou XP; Wei JY; Xu GX; Li Y; Mao LP; Huang J; Ren YL; Mei C; Wang JH; Lou YJ; Ma LY; Yu WJ; Ye L; Xie LL; Luo YW; Hu C; Niu LM; Dou MH; Jin J; Tong HY
Leuk Lymphoma; 2016; 57(6):1311-8. PubMed ID: 26372888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
